2,112
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High-Dose N-Acetylcysteine in the Prevention of COPD Exacerbations: Rationale and Design of the PANTHEON Study

, , , , , , , , , & , on behalf of the PANTHEON study committee show all
Pages 164-171 | Published online: 12 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pierachille Santus, Angelo Corsico, Paolo Solidoro, Fulvio Braido, Fabiano Di Marco & Nicola Scichilone. (2014) Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:6, pages 705-717.
Read now
Yanfei Shen, Wanru Cai, Shu Lei & Zhongheng Zhang. (2014) Effect of High/Low Dose N-Acetylcysteine on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:3, pages 351-358.
Read now

Articles from other publishers (14)

Ankit Singh, Harsh J Shah, Jacky Pariyani, Kalyani V Shinde & Paarth Kumar. (2023) A Comparative Study to Assess Efficacy and Safety of NAC Combination and NAC in Patients of Productive Cough with Acute Bronchitis. Indian Journal of Respiratory Care 12:3, pages 254-258.
Crossref
O. O. Kotova, D. A. Gassan, I. Yu. Sugaylo, D. E. Naumov, Y. G. Gorchakova & E. G. Sheludko. (2023) Oxidative stress in peripheral blood leukocytes of patients with chronic obstructive pulmonary disease. Bulletin Physiology and Pathology of Respiration:87, pages 62-70.
Crossref
Ai Luo, Xuemei Liu, Qiongqiong Hu, Mei Yang, Hongli Jiang & Wei Liu. (2022) Efficacy of N -acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol . BMJ Open 12:3, pages e053625.
Crossref
Hirofumi Kiyokawa, Yuma Hoshino, Kazuhiro Sakaguchi, Shigeo Muro & Junji Yodoi. (2021) Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD. Antioxidants 10:9, pages 1429.
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin C-1 C22-4 .
Qian Qi, Yirepanjaing Ailiyaer, Ruijuan Liu, Yan Zhang, Caiyu Li, Mingtao Liu, Xiuxiu Wang, Lijun Jing & Yu Li. (2019) Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial. Respiratory Research 20:1.
Crossref
Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding & Xin Zhao. (2019) Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). Journal of Medicinal Chemistry 62:13, pages 5944-5978.
Crossref
Phillippa Poole, Kavin Sathananthan & Rebecca Fortescue. (2019) Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Alberto Papi, Jinping Zheng, Gerard J. Criner, Leonardo M. Fabbri & Peter M.A. Calverley. (2019) Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study. Respiratory Medicine 147, pages 37-43.
Crossref
Kaushal Fowdar, Huan Chen, Zhiyi He, Jiujin Zhang, Xiaoning Zhong, Jianquan Zhang, Meihua Li & Jing Bai. (2017) The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review. Heart & Lung 46:2, pages 120-128.
Crossref
Phillippa Poole, Jimmy Chong & Christopher J Cates. (2015) Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
A. Klemmer, T. Greulich, A. R. Koczulla & C. F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD). CME 11:12, pages 52-61.
Crossref
A. Klemmer, T. Greulich, A.R. Koczulla & C.F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD)Chronic obstructive pulmonary disease (COPD). Der Internist 55:4, pages 401-414.
Crossref
Jin-Ping Zheng, Fu-Qiang Wen, Chun-Xue Bai, Huan-Ying Wan, Jian Kang, Ping Chen, Wan-Zhen Yao, Li-Jun Ma, Xia Li, Luca Raiteri, Marco Sardina, Yi Gao, Bai-Song Wang & Nan-Shan Zhong. (2014) Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. The Lancet Respiratory Medicine 2:3, pages 187-194.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.